Navigation Links
Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
Date:1/3/2008

PRINCETON, N.J., Jan. 3 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it is scheduled to present at the 26th Annual JPMorgan Healthcare Conference at 10:30 a.m. ET on Tuesday, January 8, 2008. The event will be webcast live and will be available in the Investor Relations section of the Medarex Web site at http://www.medarex.com. An archived edition of the presentation will be available following the event.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 30 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its Web site at http://www.medarex.com.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related biology technology :

1. Medarex to Present at Thomas Weisel Partners Healthcare Conference 2007
2. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
3. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Medarex to Present at the UBS Global Life Sciences Conference
6. Medarex Announces Election of Marc Rubin as New Board Member
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Avicena Group to Present at Noble Financial Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...NEAPOLIS, July 3 /- The Eniva Researc...g by the world-famous Linus Pauling,Micronutrient ...h,demonstrated the Eniva Health Supplement VIBE(R)...for human cells. This third party testing was,perf...o further identify,mechanisms by which the Eniva V...
(Date:7/3/2008)...SISSAUGA, ON, July 3 / Vaso...that it has implemented additional,restructuring p...iously,announced, the Company has been exploring s...cquisitions and mergers. In conjunction with this,...ve review of its VP,series of drugs, and has deter...
(Date:7/3/2008)... BRUNSWICK, N.J., July 3 /-...pany") (Amex: SNT ) announced today,that it has c...ance) to,supply Polyplus,s "in vivo-jetPEI" for sy...f siRNA against Factor 5A and a plasmid of the Fac...itive preclinical in vivo results,using its combin...
(Date:7/3/2008)...INE, Calif., July 3 /- Antigen Discov....), a leader in high throughput,antigen/biomarker ...ools,announced today that the Company was awarded...lergy and Infectious Diseases (NIAID) and the,Nati...million grant will,fund efforts to further develop...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2Vasogen Provides Corporate Update 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development 2
... One certain consequence of the nearly $60 billion...te cleaning. The first bigwig out the door is Dr. ...acia,s research and development operations. Today,...ompanies, announced Ando as its new chief executiv...ent of Pharmacia is leaving Pfizer," Ando says. "T...
...tical qualities that separates good business execu...ision. The American Heritage Dictionary defines vi...ption, or intelligent foresight. Many people claim...ople dont have that ability. During the Internet d...ies. They talked an interesting game, but when the...
...ant to test a theory. In short, aspects of the eco...use the migration of technology-centric and savvy ...such as Silicon Valley and Boston to smaller commu...fusion into those areas of new blood, entrepreneur...lly) new capital, will inspire a revival of many c...
...The recent Chicago biotech festivals weren,t the...ly coming of age. , ,That same week, the Illinoi...cted as its new chairman Jim L. Tyree, vice presid...t Abbott Laboratories (not to be confused with ...se it means Abbott is stepping up to the plate to ...
Other Biology Technology:Pfizer-Pharmacia Fallout Gives Celltech A CEO 2Leadership is all about Vision 2Leadership is all about Vision 3The Milkweed Effect: Disseminating Technology to New Regions 2The Milkweed Effect: Disseminating Technology to New Regions 3The Milkweed Effect: Disseminating Technology to New Regions 4Abbott Executive Jim Tyree Takes IBIO Helm 2Abbott Executive Jim Tyree Takes IBIO Helm 3Abbott Executive Jim Tyree Takes IBIO Helm 4Abbott Executive Jim Tyree Takes IBIO Helm 5Abbott Executive Jim Tyree Takes IBIO Helm 6Abbott Executive Jim Tyree Takes IBIO Helm 7Abbott Executive Jim Tyree Takes IBIO Helm 8
(Date:7/3/2008)...f aging and live longer? New Saint Louis Universit... be a promising strategy. , Calorie restriction...rats and mice. While scientists do not know how ca...ents, one popular hypothesis is that it slows agin...e (T3), which then slows metabolism and tissue agi...
(Date:7/3/2008)... Endangered wild orangutan (Pongo spp.) population... than previously estimated, according to new findi...a scientist Dr. Serge Wich and other orangutan con...nal of Conservation . , , Conservation action e...the islands of Sumatra and Borneo, must be region-...
(Date:7/2/2008)...tanding in a greenhouse at the University of Rhode...appeared that something had gone terribly wrong. ...last February in hundreds of small pots were dead....,t surprised. That,s because the pots had been si...s, and few varieties of grass can put up with that...
(Date:7/2/2008)...d the U.K. have discovered that our own body not o... ingredient in marijuana (THC), but these play an... finding on "endocannabinoids" just published onli...sue of, The FASEB Journal could lead to new drug...dry skin, and even skin-related tumors. , "Our ...
Breaking Biology News(10 mins):Looking for the Founatain of Youth? Cut your calories, research suggests 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Search for salt tolerant grasses aims to improve roadside plantings 2VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 1VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 2VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 3VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 4VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 5Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug 1147 1Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug 1147 2Springer launches Tropical Plant Biology 1792 1Springer launches Tropical Plant Biology 1792 2Despite efforts significant racial disparities in cancer therapy still exist 9139 1Despite efforts significant racial disparities in cancer therapy still exist 9139 2
... by predators, sea slugs defend themselves by ejec...ting of hydrogen peroxide, ammonia and several typ...a-based Center for Behavioral Neuroscience (CBN) h...ally inert chemicals stored separately in two glan...e edition of the Journal of Experimental Biology, ...
...ory students have discovered the antler of an Iris...an. , Although the exact age of the antler has ye...dicates that the elk (Megaloceros giganteus) lived...e open tundra landscape that was widespread in nor...e glaciers retreated northwards. , The students ...
...edical Institute researchers have discovered a vas...erns reproduction and controls the effects of repr...ir studies, the researchers found neural circuits ...s that control reproduction and brain areas that c...ules and those triggered by pheromones, chemical s...
...ith the potential to repair damaged heart muscle t...ew cartilage or skin . . . even reverse nerve dama... development of revolutionary medical treatments f...ems. , Up until now, however, stem cell research h...s by the rarity of the extraordinary cells themsel...
Other Biology News:Sea slug mixes chemical defense before firing at predators 2Students discover 11,000 year old remains of Irish Elk 2The brain is broadly wired for reproduction 2The brain is broadly wired for reproduction 3The brain is broadly wired for reproduction 4The brain is broadly wired for reproduction 5From one cell, many possible cures 2From one cell, many possible cures 3
...ector Sequencing Primer is designed for sequencing...s (Cat.# V2031, V2051, V2061). The primer hybridiz...25343, approximately 4050 base pairs upstream of t...rmine if an insert is cloned in-frame with the bio...
The versatile Zymo-Spin I-96 Plate can be used either in centrifuges or on vacuum manifolds for the large-scale (i.e., 96-well) purification of DNA and/or RNA. Its deep-well, durable polypropylene co
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin:
...he first all-inclusive collection of key procedure.... Methods developed by the leaders in Pichia expre...cols. This book will guide you from choosing the a...ruction and analysis, to production of your protei...
Biology Products: